Anson Funds Management’s Verastem VSTM Stock Holding History

Anson Funds Management’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-28,704	Closed	-$386K	–	80
2016 Q4	$386K	Buy	+28,704	New	+$427K	0.12%	48
2016 Q2	–	Sell	-15,416	Closed	-$292K	–	72
2016 Q1	$292K	Buy	15,416 +1,892	+14%	+$30.4K	0.04%	57
2015 Q4	$302K	Buy	+13,524	New	+$320K	0.1%	70

Other funds holding VSTM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

DVC

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Anson Funds Management's VSTM Position: Q1 2017 in Review

Anson Funds Management sold out of Verastem (VSTM) in Q1 2017, closing a stake of 28,704 shares — an estimated $386K sold.

Anson Funds Management first reported a position in VSTM in Q4 2015 and held it in 3 quarters. The position peaked at $386K in Q4 2016. 53 funds tracked by Wall St. Rank hold VSTM as of Q1 2017.

Anson Funds Management reported no remaining Verastem position as of Q1 2017 after selling out during the quarter.
Anson Funds Management sold 28,704 Verastem shares in Q1 2017, an estimated $386K.
Anson Funds Management first reported a position in Verastem in Q4 2015 and held it in 3 quarters.
Anson Funds Management's Verastem position peaked at $386K in Q4 2016.
53 funds tracked by Wall St. Rank held Verastem as of Q1 2017.

Based on Anson Funds Management's 13F filing for Q1 2017, filed 15 May 2017.